TABLE 1.
Strains and lines of L. panamensis evaluated in this study
| Strain group, abbreviated code | Leishmania panamensis strain |
|---|---|
| 1166 WT | MHOM/COL/86/1166 |
| Selected in vitro as promastigotes with SbIII | |
| 800.3 | MHOM/COL/86/1166-800.3 |
| 800.5 | MHOM/COL/86/1166-800.5 |
| 1000.1 | MHOM/COL/86/1166-1000.1 |
| Selected in vitro as amastigotes with SbV, SRA898 | MHOM/COL/86/1166-SRA898 |
| Clinical strains (n = 26) | |
| Isolated from patients with successful treatment | |
| 3332 | MHOM/COL/99/3332 |
| 4790 | MHOM/COL/96/4790 |
| 6138 | MHOM/COL/02/6138 |
| Isolated from patients with clinical treatment failurea | |
| 3594 (I) | MHOM/COL/02/3594 |
| 3594 (R1) | MHOM/COL/02/3594-R1 |
| 3594 (R2) | MHOM/COL/02/3594-R2 |
| 3271 (I) | MHOM/COL/98/3271 |
| 3271 (R1) | MHOM/COL/02/3594-R1 |
| 3278 (I) | MHOM/COL/98/3278 |
| 3278 (R1) | MHOM/COL/98/3278-R1 |
a
I, isolated at time of diagnosis; R1, isolated at time of first relapse; R2, isolated at time of second relapse.